Qichao Xie

917 total citations
25 papers, 611 citations indexed

About

Qichao Xie is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Qichao Xie has authored 25 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Qichao Xie's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Qichao Xie is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Qichao Xie collaborates with scholars based in China, United States and India. Qichao Xie's co-authors include Yongsheng Li, Hailin Xu, Jun He, Bo Zhu, Yupeng Yang, Bicheng Zhang, Jianfei Gao, Zhengtang Chen, Zhengtang Chen and Duyun Ye and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Science Advances.

In The Last Decade

Qichao Xie

24 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qichao Xie China 12 424 266 121 90 46 25 611
Liying Wu China 13 323 0.8× 191 0.7× 102 0.8× 52 0.6× 45 1.0× 23 520
Xundi Xu China 13 424 1.0× 206 0.8× 130 1.1× 48 0.5× 58 1.3× 31 718
Ki Cheong Park South Korea 16 360 0.8× 114 0.4× 190 1.6× 93 1.0× 55 1.2× 36 666
Donatella D’Eliseo Italy 9 200 0.5× 104 0.4× 100 0.8× 83 0.9× 25 0.5× 9 443
Xuhong Zhou China 16 580 1.4× 444 1.7× 82 0.7× 75 0.8× 51 1.1× 59 854
Peifen Cai China 10 345 0.8× 68 0.3× 144 1.2× 179 2.0× 54 1.2× 11 566
Neel Sengupta United Kingdom 10 224 0.5× 91 0.3× 128 1.1× 84 0.9× 65 1.4× 12 572
Tae‐Young Na South Korea 11 262 0.6× 90 0.3× 81 0.7× 69 0.8× 17 0.4× 14 530
Xiangshan Ren China 14 261 0.6× 72 0.3× 67 0.6× 54 0.6× 45 1.0× 31 448

Countries citing papers authored by Qichao Xie

Since Specialization
Citations

This map shows the geographic impact of Qichao Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qichao Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qichao Xie more than expected).

Fields of papers citing papers by Qichao Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qichao Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qichao Xie. The network helps show where Qichao Xie may publish in the future.

Co-authorship network of co-authors of Qichao Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Qichao Xie. A scholar is included among the top collaborators of Qichao Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qichao Xie. Qichao Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Tianyun, Qiuyang Lu, Dehong Luo, et al.. (2025). A predictive model and mechanistic study of treatment effectiveness in patients newly diagnosed with small cell lung cancer. Frontiers in Oncology. 15. 1631490–1631490.
2.
Zou, Hongbo, et al.. (2024). Mitochondrial Pyruvate Carrier 1 as a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer. Technology in Cancer Research & Treatment. 23. 2234023968–2234023968. 1 indexed citations
3.
Chen, Yihao, et al.. (2024). Network pharmacology and molecular docking reveal the mechanism of action of Bergapten against non‑small cell lung cancer. Oncology Letters. 29(2). 87–87. 3 indexed citations
4.
Wang, Jingchun, Qichao Xie, Lei Wu, et al.. (2024). Stromal interaction molecule 1/microtubule‐associated protein 1A/1B‐light chain 3B complex induces metastasis of hepatocellular carcinoma by promoting autophagy. SHILAP Revista de lepidopterología. 5(2). e482–e482. 2 indexed citations
5.
Azhati, Baihetiya, et al.. (2022). Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer. World Journal of Surgical Oncology. 20(1). 231–231. 5 indexed citations
7.
Lei, Xia, et al.. (2021). Correlation Analysis of circRNA Circ_0071662 in Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma. International Journal of General Medicine. Volume 14. 10423–10428. 4 indexed citations
8.
Liu, Yang, Hongbo Zou, Qichao Xie, et al.. (2021). Ribonucleic acid-binding protein CPSF6 promotes glycolysis and suppresses apoptosis in hepatocellular carcinoma cells by inhibiting the BTG2 expression. BioMedical Engineering OnLine. 20(1). 67–67. 9 indexed citations
9.
Zou, Hongbo, Anmei Zhang, Songtao Wang, et al.. (2019). MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway. Cell Death and Disease. 10(3). 148–148. 26 indexed citations
10.
He, Jun, et al.. (2017). Circular RNAs and cancer. Cancer Letters. 396. 138–144. 177 indexed citations
11.
Zhu, Bo, et al.. (2015). MDM2 SNP309 variation confers the susceptibility to hepatocellular cancer: a meta-analysis based on 4271 subjects.. PubMed. 8(4). 5822–30. 4 indexed citations
12.
Zhuo, Wenlei, Liang Zhang, Yi Zhun Zhu, et al.. (2015). Valproic acid, an inhibitor of class I histone deacetylases, reverses acquired Erlotinib-resistance of lung adenocarcinoma cells: a Connectivity Mapping analysis and an experimental study.. PubMed. 5(7). 2202–11. 11 indexed citations
13.
Li, Yongsheng, Bo Guo, Qichao Xie, et al.. (2015). STIM1 Mediates Hypoxia-Driven Hepatocarcinogenesis via Interaction with HIF-1. Cell Reports. 12(3). 388–395. 63 indexed citations
15.
Xie, Qichao & Yupeng Yang. (2014). Anti-proliferative of physcion 8-O-β-glucopyranoside isolated from Rumex japonicus Houtt. on A549 cell lines via inducing apoptosis and cell cycle arrest. BMC Complementary and Alternative Medicine. 14(1). 377–377. 37 indexed citations
17.
Sun, Jianguo, Rongxia Liao, Jun Qiu, et al.. (2010). Microarray-based analysis of microRNA expression in breast cancer stem cells. Journal of Experimental & Clinical Cancer Research. 29(1). 174–174. 25 indexed citations
19.
Wang, Jun, Bicheng Zhang, Yan Guo, et al.. (2008). Artemisinin Inhibits Tumor Lymphangiogenesis by Suppression of Vascular Endothelial Growth Factor C. Pharmacology. 82(2). 148–155. 39 indexed citations
20.
Xie, Qichao, Yide Hu, Lingli Wang, et al.. (2005). The co-transfection of p16INK4a and p14ARF genes into human lung cancer cell line A549 and the effects on cell growth and chemosensitivity. Colloids and Surfaces B Biointerfaces. 46(3). 188–196. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026